{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:37:21Z","timestamp":1769557041234,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,9,21]],"date-time":"2011-09-21T00:00:00Z","timestamp":1316563200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s10147-011-0320-5","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T01:35:25Z","timestamp":1316482525000},"page":"491-497","source":"Crossref","is-referenced-by-count":4,"title":["A phase I trial of arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for unresectable biliary tract cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Tsuyoshi","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotoshi","family":"Ishiwatari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Miyanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Kobune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishu","family":"Takimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,21]]},"reference":[{"key":"320_CR1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00534-007-1279-5","volume":"15","author":"S Kondo","year":"2008","unstructured":"Kondo S, Takada T, Miyazaki M et al (2008) Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg 15:41\u201354","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"320_CR2","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","volume":"366","author":"SA Khan","year":"2005","unstructured":"Khan SA, Thomas HC, Davidson BR et al (2005) Cholangiocarcinoma. Lancet 366:1303\u20131314","journal-title":"Lancet"},{"key":"320_CR3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.amjsurg.2007.11.011","volume":"196","author":"S Gourgiotis","year":"2008","unstructured":"Gourgiotis S, Kocher HM, Solaini L et al (2008) Gallbladder cancer. Am J Surg 196:252\u2013264","journal-title":"Am J Surg"},{"key":"320_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00534-008-0015-0","volume":"16","author":"S Miyakawa","year":"2009","unstructured":"Miyakawa S, Ishihara S, Horiguchi A et al (2009) Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan. J Hepatobiliary Pancreat Surg 16:1\u20137","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"320_CR5","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/jjco\/hyp106","volume":"39","author":"T Matsuda","year":"2009","unstructured":"Matsuda T, Marugame T, Kamo K et al (2009) Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Jpn J Clin Oncol 39:850\u2013858","journal-title":"Jpn J Clin Oncol"},{"key":"320_CR6","first-page":"2020","volume":"45","author":"T Takada","year":"1998","unstructured":"Takada T, Nimura Y, Katoh H et al (1998) Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial. Hepatogastroenterology 45:2020\u20132026","journal-title":"Hepatogastroenterology"},{"key":"320_CR7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/oxfordjournals.annonc.a010676","volume":"7","author":"B Glimelius","year":"1996","unstructured":"Glimelius B, Hoffman K, Sjoden PO et al (1996) Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 7:593\u2013600","journal-title":"Ann Oncol"},{"key":"320_CR8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1023\/A:1016209901417","volume":"20","author":"R Kuhn","year":"2002","unstructured":"Kuhn R, Hribaschek A, Eichelmann K et al (2002) Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas. Invest New Drugs 20:351\u2013356","journal-title":"Invest New Drugs"},{"key":"320_CR9","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1002\/cncr.24970","volume":"116","author":"S Cereda","year":"2010","unstructured":"Cereda S, Passoni P, Reni M et al (2010) The cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG) regimen in advanced biliary tract adenocarcinoma. Cancer 116:2208\u20132214","journal-title":"Cancer"},{"key":"320_CR10","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/sj.bjc.6601796","volume":"90","author":"C Hsu","year":"2004","unstructured":"Hsu C, Shen YC, Yang CH et al (2004) Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil\/leucovorin for locally advanced or metastatic carcinoma of the biliary tract. Br J Cancer 90:1715\u20131719","journal-title":"Br J Cancer"},{"key":"320_CR11","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/annonc\/mdh351","volume":"15","author":"T Andre","year":"2004","unstructured":"Andre T, Tournigand C, Rosmorduc O et al (2004) Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol 15:1339\u20131343","journal-title":"Ann Oncol"},{"key":"320_CR12","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH et al (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362:1273\u20131281","journal-title":"N Engl J Med"},{"key":"320_CR13","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/cncr.23787","volume":"113","author":"JH Kim","year":"2008","unstructured":"Kim JH, Yoon HK, Sung KB et al (2008) Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes. Cancer 113:1614\u20131622","journal-title":"Cancer"},{"key":"320_CR14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11605-007-0312-y","volume":"12","author":"NJ Gusani","year":"2008","unstructured":"Gusani NJ, Balaa FK, Steel JL et al (2008) Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience. J Gastrointest Surg 12:129\u2013137","journal-title":"J Gastrointest Surg"},{"key":"320_CR15","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1200\/JCO.2005.01.5354","volume":"23","author":"E Ben-Josef","year":"2005","unstructured":"Ben-Josef E, Normolle D, Ensminger WD et al (2005) Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol 23:8739\u20138747","journal-title":"J Clin Oncol"},{"key":"320_CR16","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1002\/cncr.20265","volume":"100","author":"S Matsumoto","year":"2004","unstructured":"Matsumoto S, Kiyosue H, Komatsu E et al (2004) Radiotherapy combined with transarterial infusion chemotherapy and concurrent infusion of a vasoconstrictor agent for nonresectable advanced hepatic hilar duct carcinoma. Cancer 100:2422\u20132429","journal-title":"Cancer"},{"key":"320_CR17","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/annonc\/mdf262","volume":"13","author":"M Cantore","year":"2002","unstructured":"Cantore M, Rabbi C, Guadagni S et al (2002) Intra-arterial hepatic chemotherapy combined with continuous infusion of 5-fluorouracil in patients with metastatic cholangiocarcinoma. Ann Oncol 13:1687\u20131688","journal-title":"Ann Oncol"},{"key":"320_CR18","first-page":"3009","volume":"27","author":"A Mambrini","year":"2007","unstructured":"Mambrini A, Guglielmi A, Pacetti P et al (2007) Capecitabine plus hepatic intra-arterial epirubicin and cisplatin in unresectable biliary cancer: a phase II study. Anticancer Res 27:3009\u20133013","journal-title":"Anticancer Res"},{"key":"320_CR19","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.clon.2007.08.013","volume":"19","author":"A Mambrini","year":"2007","unstructured":"Mambrini A, Del Freo A, Pacetti P et al (2007) Intra-arterial and systemic chemotherapy plus external hyperthermia in unresectable biliary cancer. Clin Oncol (R Coll Radiol) 19:805\u2013806","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"320_CR20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jso.20290","volume":"91","author":"MK Bode","year":"2005","unstructured":"Bode MK, Perala J, Makela JT et al (2005) Intra-arterial chemotherapy with mitomycin C in gallbladder cancer: a follow-up study. J Surg Oncol 91:102\u2013106","journal-title":"J Surg Oncol"},{"key":"320_CR21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00330-007-0781-0","volume":"18","author":"TJ Vogl","year":"2008","unstructured":"Vogl TJ, Zangos S, Eichler K et al (2008) Palliative hepatic intraarterial chemotherapy (HIC) using a novel combination of gemcitabine and mitomycin C: results in hepatic metastases. Eur Radiol 18:468\u2013476","journal-title":"Eur Radiol"},{"key":"320_CR22","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/annonc\/mdp029","volume":"20","author":"WR Jarnagin","year":"2009","unstructured":"Jarnagin WR, Schwartz LH, Gultekin DH et al (2009) Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Ann Oncol 20:1589\u20131595","journal-title":"Ann Oncol"},{"key":"320_CR23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/jjco\/hyn015","volume":"38","author":"K Miyanishi","year":"2008","unstructured":"Miyanishi K, Ishiwatari H, Hayashi T et al (2008) A phase I trial of arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for unresectable advanced pancreatic cancer after vascular supply distribution via superselective embolization. Jpn J Clin Oncol 38:268\u2013274","journal-title":"Jpn J Clin Oncol"},{"key":"320_CR24","first-page":"251a","volume":"17","author":"L Schulz","year":"1998","unstructured":"Schulz L, Schalhorn W, Wilmanns W et al (1998) Synergistic interaction of gemcitabine and 5-fluorouracil in colon cancer cells. Proc Am Soc Clin Oncol 17:251a abstr 965","journal-title":"Proc Am Soc Clin Oncol"},{"key":"320_CR25","first-page":"1088","volume":"43","author":"N Sawada","year":"2002","unstructured":"Sawada N, Fujimoto-Ouchi K, Ishikawa T et al (2002) Antitumor activity of combination therapy with capecitabine plus vinorelbine, and capecitabine plus gemcitabine in human tumor xenograft models. Proc Am Assoc Cancer Res 43:1088 (abstr 5388)","journal-title":"Proc Am Assoc Cancer Res"},{"key":"320_CR26","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1200\/JCO.2001.19.20.4089","volume":"19","author":"V Gebbia","year":"2001","unstructured":"Gebbia V, Giuliani F, Maiello E et al (2001) Treatment of inoperable and\/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study. J Clin Oncol 19:4089\u20134091","journal-title":"J Clin Oncol"},{"key":"320_CR27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00534-006-1153-x","volume":"14","author":"F Miura","year":"2007","unstructured":"Miura F, Takada T, Kawarada Y et al (2007) Flowcharts for the diagnosis and treatment of acute cholangitis and cholecystitis: Tokyo guidelines. J Hepatobiliary Pancreat Surg 14:27\u201334","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"320_CR28","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2165\/00003088-200544090-00005","volume":"44","author":"AI Shamseddine","year":"2005","unstructured":"Shamseddine AI, Khalifeh MJ, Mourad FH et al (2005) Comparative pharmacokinetics and metabolic pathway of gemcitabine during intravenous and intra-arterial delivery in unresectable pancreatic cancer patients. Clin Pharmacokinet 44:957\u2013967","journal-title":"Clin Pharmacokinet"},{"key":"320_CR29","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1200\/JCO.1995.13.12.2968","volume":"13","author":"DJ Kerr","year":"1995","unstructured":"Kerr DJ, Ledermann JA, McArdle CS et al (1995) Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracil. J Clin Oncol 13:2968\u20132972","journal-title":"J Clin Oncol"},{"key":"320_CR30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1067\/mge.2003.66","volume":"57","author":"M Kaassis","year":"2003","unstructured":"Kaassis M, Boyer J, Dumas R et al (2003) Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc 57:178\u2013182","journal-title":"Gastrointest Endosc"},{"key":"320_CR31","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.gie.2005.11.052","volume":"63","author":"C Soderlund","year":"2006","unstructured":"Soderlund C, Linder S (2006) Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc 63:986\u2013995","journal-title":"Gastrointest Endosc"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-011-0320-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-011-0320-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-011-0320-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T01:42:00Z","timestamp":1712886120000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-011-0320-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,21]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["320"],"URL":"https:\/\/doi.org\/10.1007\/s10147-011-0320-5","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,21]]}}}